Economic evaluation of the treatment of clostridium difficile

16 Feb 2017

CBEH Professor and Acting Director Professor Luke Connelly has published an article with colleagues at QUT that examines an effective and cost-effective way to treat recurrent clostridium difficile. Clostridium difficile is a common bacterial infection of the gut that may become resistant to treatment with potentially fatal consequences. Their work was published in the Journal of Gastroenterology and Hepatology.